Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M309207200 on January 6, 2004 Originally published In Press as doi:10.1074/jbc.M309207200 on December 19, 2003

J. Biol. Chem., Vol. 279, Issue 11, 10338-10345, March 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/11/10338    most recent
M309207200v2
M309207200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudreau, R.
Right arrow Articles by Rola-Pleszczynski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudreau, R.
Right arrow Articles by Rola-Pleszczynski, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Determinants Regulating Expression of the High Affinity Leukotriene B4 Receptor

INVOLVEMENT OF DILEUCINE MOTIFS AND {alpha}-HELIX VIII*

Rémi Gaudreau, Marie-Eve Beaulieu{ddagger}, Zhangguo Chen, Christian Le Gouill, Pierre Lavigne{ddagger}, Jana Stanková, and Marek Rola-Pleszczynski§

From the Immunology Division, Departments of Pediatrics and {ddagger}Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada

Mutational analysis of determinants located in the C-terminal (C) tail of the high affinity leukotriene (LT) B4 receptor, BLT1, was performed to assess their significance in BLT1 trafficking. When expressed in COS-7 cells, a BLT1 deletion mutant lacking the C-tail (G291stop) displayed higher numbers of binding sites and increased signal transduction compared with wild-type (WT) BLT1. Addition of the C-tail from either the platelet-activating factor receptor or the LTD4 receptor, CysLT1, did not restore WT phenotype. Moreover, the number of LTB4 binding sites was higher in the chimeras than in the WT BLT1, suggesting the requirement for specific structural determinants within the BLT1 C-tail. Elimination of a distal C-tail dileucine motif (Leu304-Leu305), but not the proximal (Leu292-Leu293) motif, altered BLT1 pharmacological characteristics and caused a moderate constitutive receptor activation. Surprisingly, all mutant receptors were efficiently delivered to the plasma membrane, but not to a greater extent than WT BLT1, as assessed by flow cytometry. Furthermore, substitution of Leu304-Leu305 prevented LTB4-induced BLT1 internalization. Molecular modeling of BLT1 on the bovine rhodopsin receptor scaffold strongly suggested the involvement of the distal dileucine motif (Leu304-Leu305) in a hydrophobic core, including intrahelical interactions within {alpha}-helix VIII and interhelical interactions with residues of helix I. Disruption of this hydrophobic core is proposed to increase the population of receptors in the active form, to restrain their trafficking and to facilitate the activation of BLT1 as indicated by the increased maximal level of binding of the ligand and constitutive activation of the receptor.


Received for publication, August 19, 2003 , and in revised form, December 16, 2003.

* This work was supported by a grant from the Canadian Institutes of Health Research and by a Studentship (to R. G.) from the Fonds pour les Chercheurs et l'Aide à la Recherche (FCAR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Immunology Division, Dept. of Pediatrics, Faculty of Medicine, Université de Sherbrooke, 3001 N. 12th Avenue, Sherbrooke, QC J1H 5N4, Canada. Tel.: 819-346-1110 (ext. 14851); Fax: 819-564-5215; E-mail: marek.rola-pleszczynski{at}usherbrooke.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Kuniyeda, T. Okuno, K. Terawaki, M. Miyano, T. Yokomizo, and T. Shimizu
Identification of the Intracellular Region of the Leukotriene B4 Receptor Type 1 That Is Specifically Involved in Gi Activation
J. Biol. Chem., February 9, 2007; 282(6): 3998 - 4006.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Carrel, M. Hamon, and M. Darmon
Role of the C-terminal di-leucine motif of 5-HT1A and 5-HT1B serotonin receptors in plasma membrane targeting
J. Cell Sci., October 15, 2006; 119(20): 4276 - 4284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Okuno, T. Yokomizo, T. Hori, M. Miyano, and T. Shimizu
Leukotriene B4 Receptor and the Function of Its Helix 8
J. Biol. Chem., September 16, 2005; 280(37): 32049 - 32052.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. R. Jala, W.-H. Shao, and B. Haribabu
Phosphorylation-independent {beta}-Arrestin Translocation and Internalization of Leukotriene B4 Receptors
J. Biol. Chem., February 11, 2005; 280(6): 4880 - 4887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement